Moreover, tumor endothelial cells show different responsiveness to epidermal growth factor (EGF) (Amin et al., 2006), adrenomedullin (Tsuchiya et al., 2010), and VEGF (Matsuda et al., 2010) compared with normal endothelial cells. This evidence concerns the gene EGF and neoplasm.